Baird Financial Group Inc. decreased its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) by 21.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,260 shares of the medical instruments supplier’s stock after selling 1,160 shares during the quarter. Baird Financial Group Inc.’s holdings in Merit Medical Systems were worth $231,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MMSI. Nisa Investment Advisors LLC increased its holdings in shares of Merit Medical Systems by 27.7% during the first quarter. Nisa Investment Advisors LLC now owns 3,690 shares of the medical instruments supplier’s stock valued at $245,000 after acquiring an additional 800 shares in the last quarter. Mutual of America Capital Management LLC lifted its holdings in Merit Medical Systems by 5.5% in the 1st quarter. Mutual of America Capital Management LLC now owns 7,322 shares of the medical instruments supplier’s stock worth $487,000 after purchasing an additional 380 shares in the last quarter. State of New Jersey Common Pension Fund D increased its stake in Merit Medical Systems by 8.8% in the 1st quarter. State of New Jersey Common Pension Fund D now owns 44,097 shares of the medical instruments supplier’s stock worth $2,933,000 after acquiring an additional 3,551 shares during the last quarter. Versor Investments LP increased its stake in Merit Medical Systems by 55.9% in the 1st quarter. Versor Investments LP now owns 11,057 shares of the medical instruments supplier’s stock worth $736,000 after acquiring an additional 3,963 shares during the last quarter. Finally, Envestnet Asset Management Inc. increased its position in shares of Merit Medical Systems by 14.3% during the 1st quarter. Envestnet Asset Management Inc. now owns 47,203 shares of the medical instruments supplier’s stock valued at $3,140,000 after purchasing an additional 5,908 shares during the last quarter. Hedge funds and other institutional investors own 94.52% of the company’s stock.
Merit Medical Systems Trading Down 0.4 %
Shares of NASDAQ MMSI opened at $71.48 on Thursday. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.35 and a quick ratio of 1.19. The stock has a market capitalization of $4.07 billion, a P/E ratio of 66.19, a price-to-earnings-growth ratio of 2.50 and a beta of 1.04. Merit Medical Systems, Inc. has a 1-year low of $50.46 and a 1-year high of $72.40. The business has a fifty day moving average price of $61.90 and a 200 day moving average price of $59.18.
Analyst Ratings Changes
Merit Medical Systems Company Profile
Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.
- Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
- Institutional Support for Analog Devices Remains High
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Three CBD Stocks to Dominate a Budding Industry
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.